• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿莱斯纤维蛋白原:一种异常纤维蛋白原血症(γ-天冬氨酸(330)→缬氨酸)的纯合病例,其特征为纤维蛋白聚合位点“a”存在缺陷。

Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".

作者信息

Lounes K C, Soria C, Mirshahi S S, Desvignes P, Mirshahi M, Bertrand O, Bonnet P, Koopman J, Soria J

机构信息

Laboratoire Sainte Marie, Laboratoire de Biochimie A, and INSERM E 99-12, Hôtel-Dieu, Paris, France.

出版信息

Blood. 2000 Nov 15;96(10):3473-9.

PMID:11071644
Abstract

Congenital homozygous dysfibrinogenemia was diagnosed in a man with a history of 2 thrombotic strokes before age 30. His hemostatic profile was characterized by a dramatically prolonged plasma thrombin clotting time, and no clotting was observed with reptilase. Complete clotting of the abnormal fibrinogen occurred after a prolonged incubation of plasma with thrombin. The release of fibrinopeptides A and B by thrombin and of fibrinopeptide A by reptilase were both normal. Thrombin-induced fibrin polymerization was impaired, and no polymerization occurred with reptilase. The polymerization defect was characterized by a defective site "a," resulting in an absence of interaction between sites A and a, indicated by the lack of fragment D(1) (or fibrinogen) binding to normal fibrin monomers depleted in fibrinopeptide A only (Des-AA fm). By SDS-PAGE, the defect was detected on the gamma-chain and in its fragment D(1). The molecular defect determined by analysis of genomic DNA showed a single base change (A-->T) in exon VIII of the gamma-chain. The resulting change in the amino acid structure is gamma 330 aspartic acid (GAT) --> valine (GTT). It is concluded that the residue gamma-Asp(330) is essential for the normal functioning of the polymerization site a on the fibrinogen gamma-chain.

摘要

一名在30岁前有2次血栓性中风病史的男性被诊断为先天性纯合子异常纤维蛋白原血症。他的止血特征表现为血浆凝血酶凝血时间显著延长,用蛇毒凝血酶检测时未观察到凝血现象。血浆与凝血酶长时间孵育后,异常纤维蛋白原完全凝血。凝血酶释放纤维蛋白肽A和B以及蛇毒凝血酶释放纤维蛋白肽A均正常。凝血酶诱导的纤维蛋白聚合受损,蛇毒凝血酶不能诱导聚合。聚合缺陷的特征是存在缺陷位点“a”,导致位点A和a之间缺乏相互作用,这表现为片段D(1)(或纤维蛋白原)不能与仅缺乏纤维蛋白肽A的正常纤维蛋白单体(Des-AA fm)结合。通过SDS-PAGE分析,在γ链及其片段D(1)上检测到缺陷。通过对基因组DNA的分析确定的分子缺陷显示γ链外显子VIII中有一个单碱基变化(A→T)。氨基酸结构的相应变化是γ330天冬氨酸(GAT)→缬氨酸(GTT)。得出的结论是,γ-Asp(330)残基对于纤维蛋白原γ链上聚合位点a的正常功能至关重要。

相似文献

1
Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".阿莱斯纤维蛋白原:一种异常纤维蛋白原血症(γ-天冬氨酸(330)→缬氨酸)的纯合病例,其特征为纤维蛋白聚合位点“a”存在缺陷。
Blood. 2000 Nov 15;96(10):3473-9.
2
Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.纤维蛋白原圣加仑I(γ292位甘氨酸突变为缬氨酸):结构改变导致聚合缺陷和纤维蛋白原溶解的证据
Thromb Haemost. 1999 Feb;81(2):268-74.
3
Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.瓜雷纳斯纤维蛋白原I:一种新型异常纤维蛋白原血症的部分特征,其纤维蛋白肽释放速率改变且聚合受损。
Thromb Res. 1995 Apr 15;78(2):95-106. doi: 10.1016/0049-3848(95)00038-0.
4
Two novel mutations in the fibrinogen γ nodule.纤维蛋白原γ 节中的两个新突变。
Thromb Res. 2014 Oct;134(4):901-8. doi: 10.1016/j.thromres.2014.07.021. Epub 2014 Jul 21.
5
Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr.与凝血酶结合缺陷及血栓形成倾向相关的那不勒斯纤维蛋白原的分子基础。Bβ68位丙氨酸纯合性替代为苏氨酸。
J Clin Invest. 1992 Jul;90(1):238-44. doi: 10.1172/JCI115841.
6
Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.纤维蛋白原巴斯蒂亚(γ318 天冬氨酸→酪氨酸):一种以纤维蛋白聚合缺陷为特征的新型异常纤维蛋白原。
Thromb Haemost. 1999 Dec;82(6):1639-43.
7
Thrombotic dysfibrinogenemia. Fibrinogen "Caracas V" relation between very tight fibrin network and defective clot degradability.血栓性异常纤维蛋白原血症。纤维蛋白原“加拉加斯V型”:紧密的纤维蛋白网络与凝血块降解缺陷之间的关系。
Thromb Res. 2000 Jul 15;99(2):187-93. doi: 10.1016/s0049-3848(00)00235-8.
8
Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.纤维蛋白原松本I型:一种与纤维蛋白聚合缺陷相关的γ364位天冬氨酸替换为组氨酸(GAT→CAT)的突变
Thromb Haemost. 1996 Jun;75(6):887-91.
9
Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.重组γT305A纤维蛋白原表明,由于“A”孔和钙结合位点的异常功能,纤维蛋白聚合严重受损。
Thromb Res. 2014 Aug;134(2):518-25. doi: 10.1016/j.thromres.2014.06.002. Epub 2014 Jun 11.
10
Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.纤维蛋白原伯尔尼IV型、伯尔尼V型和米兰XI型:Aα链凝血酶裂解位点存在氨基酸取代的三种功能异常变体。
Blood Coagul Fibrinolysis. 1999 Mar;10(2):93-9.

引用本文的文献

1
Fibrinogen post-translational modifications are biochemical determinants of fibrin clot properties and interactions.纤维蛋白原的翻译后修饰是纤维蛋白凝块特性及相互作用的生化决定因素。
FEBS J. 2025 Jan;292(1):11-27. doi: 10.1111/febs.17236. Epub 2024 Aug 23.
2
Pseudohomozygous dysfibrinogenemia.假性纯合子异常纤维蛋白原血症
Res Pract Thromb Haemost. 2021 Aug 21;5(6):e12568. doi: 10.1002/rth2.12568. eCollection 2021 Aug.
3
Identification of novel mutations in patients with fibrinogen disorders and genotype/phenotype correlations.
鉴定纤维蛋白原紊乱患者的新型突变与基因型/表型相关性。
Blood Transfus. 2019 May;17(3):247-254. doi: 10.2450/2018.0123-18. Epub 2018 Oct 8.